Ph1/2a FIH study to assess activity of DB-1311 in subjects with Solid Tumors

Phase I/II Clinical Trial

A Phase 1/2a Multicenter Open-Label First in Human Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors (DB-1311-O-1001)

Indication: Cervical Cancer, Cervical Cancer, Cervical Cancer, Esophageal Cancer, Esophageal Cancer, Esophageal Cancer, Liver Cancer, Liver Cancer, Liver Cancer, Melanoma, Melanoma, Melanoma
Trial Number: 05914116
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations